Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory

Biol Psychiatry. 2010 Feb 1;67(3):246-54. doi: 10.1016/j.biopsych.2009.08.011. Epub 2009 Oct 28.

Abstract

Background: Although dopamine D1 receptors are involved in working memory, how D1 receptors contribute to this process remains unclear. Numerous studies have shown that D1 receptors have extensive functional interaction with N-methyl-D-aspartate (NMDA) receptor. Our group previously demonstrated that D1 receptors were able to regulate NMDA receptor functions through direct protein-protein interactions involving the carboxyl terminals of D1 receptors and NMDA receptor NR1a and NR2A subunits respectively. In this study, we explored the effects of the D1-NR1 interaction on NMDA receptor-dependent long-term potentiation (LTP) and working memory by using the TAT-conjugated interfering peptide (TAT-D1-t2).

Methods: Miniature excitatory postsynaptic currents are recorded in rat hippocampal primary cultures. Coimmunoprecipitation and calcium/calmodulin-dependent protein kinase II (CaMKII) activity are measured in hippocampal slices and hippocampal neurons under the specified experimental conditions, respectively. Working memory was assessed using a delayed match-to-place protocol in the Morris Water Maze following administration of the TAT-D1-t2 peptide.

Results: Electrophysiology experiments showed that activation of D1 receptor upregulates NMDA receptor-mediated LTP in a CaMKII-dependent manner. Furthermore, D1 receptor agonist stimulation promotes the NR1-CaMKII coupling and enhances the CaMKII activity; and the D1 receptor-mediated effects can be blocked by the application of the TAT-D1-t2 peptide. Interestingly, animals injected with TAT-D1-t2 peptide exhibited significantly impaired working memory.

Conclusions: Our study showed a critical role of NMDA-D1 direct protein-protein interaction in NMDA receptor-mediated LTP and working memory and implicated the involvement of CaMKII in this process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzazepines / pharmacology
  • Biophysics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cells, Cultured
  • Dopamine Agonists / pharmacology
  • Electric Stimulation / methods
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Agonists / pharmacology*
  • Hippocampus / cytology
  • Immunoprecipitation / methods
  • In Vitro Techniques
  • Long-Term Potentiation / drug effects*
  • Long-Term Potentiation / physiology
  • Male
  • Maze Learning / drug effects
  • Memory, Short-Term / drug effects*
  • Memory, Short-Term / physiology
  • Mice
  • Mice, Inbred C57BL
  • N-Methylaspartate / pharmacology*
  • Neurons / drug effects
  • Neurons / physiology
  • Patch-Clamp Techniques
  • Peptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Receptors, Dopamine D1 / chemistry
  • Receptors, Dopamine D1 / metabolism*
  • Receptors, N-Methyl-D-Aspartate / metabolism*

Substances

  • Benzazepines
  • Dopamine Agonists
  • Enzyme Inhibitors
  • Excitatory Amino Acid Agonists
  • Peptides
  • Receptors, Dopamine D1
  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • SK&F 81297
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2